The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 · New England Journal of Medicine · 8,985 citations
https://doi.org/10.1056/nejm199909023411001
W
Willem J. Remme
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
232
Papers
29.4K
Citations
49
h-index
110
i10-index
Willem J. Remme is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiac electrophysiology and arrhythmias & Blood Pressure and Hypertension Studies. The author has an h-index of 49, co-authored 198 publications.
Papers by this author
worksComprehensive Guidelines for the Diagnosis and Treatment of Chronic Heart Failure Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
2002 · European Journal of Heart Failure · 454 citations
https://doi.org/10.1016/s1388-9842(01)00231-8
Rationale and Design of the Carvedilol or Metoprolol European Trial in Patients with Chronic Heart Failure: COMET
2002 · European Journal of Heart Failure · 88 citations
https://doi.org/10.1016/s1388-9842(02)00025-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat